Pharmacokinetics of ascending doses of ivermectin in Trichuris trichiura-infected children aged 2–12 years-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetics of ascending doses of ivermectin in Trichuris trichiura-infected children aged 2–12 years

Published:2019-03-11 Issue:6 Volume:74 Page:1642-1647
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Schulz Jessica D¹²,Coulibaly Jean T¹²³⁴,Schindler Christian¹²,Wimmersberger David¹²,Keiser Jennifer¹²

Affiliation:

1. Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland

2. University of Basel, Basel, Switzerland

3. Unité de Formation et de Recherche Biosciences, Université Félix Houphouët–Boigny, Abidjan, Côte d’Ivoire

4. Centre Suisse de Recherches Scientifiques en Côte d’Ivoire, Abidjan, Côte d’Ivoire

Funder

Bill & Melinda Gates foundation

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/74/6/1642/28666518/dkz083.pdf

Reference28 articles.

1. Ivermectin: panacea for resource-poor communities?;Omura;Trends Parasitol,2014

2. The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug;Juarez;Am J Cancer Res,2018

3. Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial;Smit;Lancet Infect Dis,2018

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg;Pharmaceutics;2024-09-07

2. Novel Patient‐Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use;The Journal of Clinical Pharmacology;2024-05-30

3. Efficacy and safety of moxidectin compared with ivermectin against Strongyloides stercoralis infection in adults in Laos and Cambodia: a randomised, double-blind, non-inferiority, phase 2b/3 trial;The Lancet Infectious Diseases;2024-02

4. Antiparasitic activity of ivermectin: Four decades of research into a “wonder drug”;European Journal of Medicinal Chemistry;2023-12

5. Evidence-based indications for ivermectin in parasitic diseases: An integrated approach to context and challenges in Peru;Parasite Epidemiology and Control;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3